CA2244675A1 - Preparation pharmaceutique combinee et leur utilisation pour traiter les troubles gynecologiques - Google Patents

Preparation pharmaceutique combinee et leur utilisation pour traiter les troubles gynecologiques Download PDF

Info

Publication number
CA2244675A1
CA2244675A1 CA 2244675 CA2244675A CA2244675A1 CA 2244675 A1 CA2244675 A1 CA 2244675A1 CA 2244675 CA2244675 CA 2244675 CA 2244675 A CA2244675 A CA 2244675A CA 2244675 A1 CA2244675 A1 CA 2244675A1
Authority
CA
Canada
Prior art keywords
lhrh
treatment
administration
raloxifen
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2244675
Other languages
English (en)
Inventor
Klaus Stockemann
Peter Muhn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19604231A external-priority patent/DE19604231A1/de
Application filed by Individual filed Critical Individual
Publication of CA2244675A1 publication Critical patent/CA2244675A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne une préparation pharmaceutique combinée contenant des analogues de LHRH et des anti-oestrogènes à effet oestrogène tissulo-sélectif. Elle concerne également l'utilisation de cette préparation pharmaceutique combinée pour traiter des troubles gynécologiques, notamment l'endométriose et les myomes.
CA 2244675 1996-01-29 1997-01-29 Preparation pharmaceutique combinee et leur utilisation pour traiter les troubles gynecologiques Abandoned CA2244675A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19604231.3 1996-01-29
DE19604231A DE19604231A1 (de) 1996-01-29 1996-01-29 Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
PCT/EP1997/000395 WO1997027863A1 (fr) 1996-01-29 1997-01-29 Preparation pharmaceutique combinee contenant des analogues de lhrh et des anti-oestrogenes pour traiter des troubles gynecologiques

Publications (1)

Publication Number Publication Date
CA2244675A1 true CA2244675A1 (fr) 1997-08-07

Family

ID=29421547

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2244675 Abandoned CA2244675A1 (fr) 1996-01-29 1997-01-29 Preparation pharmaceutique combinee et leur utilisation pour traiter les troubles gynecologiques

Country Status (1)

Country Link
CA (1) CA2244675A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011156908A1 (fr) * 2010-06-16 2011-12-22 Endorecherche, Inc. Méthodes de traitement prophylactique ou thérapeutique de maladies liées aux œstrogènes

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011156908A1 (fr) * 2010-06-16 2011-12-22 Endorecherche, Inc. Méthodes de traitement prophylactique ou thérapeutique de maladies liées aux œstrogènes
CN103037862A (zh) * 2010-06-16 2013-04-10 恩多研究公司 治疗或预防雌激素相关疾病的方法
EA026675B1 (ru) * 2010-06-16 2017-05-31 Эндорешерш, Инк. Способы лечения или предотвращения эстрогензависимых заболеваний
CN107693794A (zh) * 2010-06-16 2018-02-16 恩多研究公司 治疗或预防雌激素相关疾病的方法
US11576891B2 (en) 2010-06-16 2023-02-14 Endorecherche, Inc. Methods of treating or preventing estrogen-related diseases

Similar Documents

Publication Publication Date Title
RU2110274C1 (ru) Способ лечения состояния, зависящего от эстрогенов яичников
Reissmann et al. The LHRH antagonist cetrorelix: a review
Diedrich et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation
Shoham et al. Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone
JP2703243B2 (ja) 避妊薬用としての性ステロイド放出と組合わされた黄体形成ホルモン放出ホルモン組成物の連続放出
US7309691B2 (en) Combined pharmaceutical preparation containing LHRH-analogous substances and anti estrogens for treating gynaecological disorders
US5130137A (en) Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders
NO321502B1 (no) Progestogen-fritt kombinert preparat for behandling av benigne gynekologiske sykdommer
WO2000007599A1 (fr) Prevention de signes ou symptomes d'endometriose
US20110306547A1 (en) Lhrh - antagonists in the treatment of fertility disorders
EP0994718B1 (fr) Antagoniste de gonadoliberine
Felberbaum et al. Will GnRH antagonists assist in the treatment of benign gynaecological diseases?
JP4418102B2 (ja) ジエノゲストを有効成分とする子宮筋腫治療剤
CA2244675A1 (fr) Preparation pharmaceutique combinee et leur utilisation pour traiter les troubles gynecologiques
BARBIERI Gonadotropin-releasing hormone agonists: treatment of endometriosis
BG63363B1 (bg) Използване на антагонист на gnrh за получаване нафармацевтичен състав за лечение на гонадостероидно зависими заболявания
Bergqvist Current drug therapy recommendations for the treatment of endometriosis
AU2002230464A1 (en) Combination therapy for estrogen-dependent disorders
AU761274B2 (en) Pharmaceutical combination preparation that consists of LHRH-analogues and antiestrogens for treating gynecological disorders
Neves-e-Castro et al. Use of luteinizing hormone-releasing hormone analogs in non-neoplastic gynecologic conditions
Hornstein et al. Endometriosis: Long-term treatment with gonadotropin-releasing hormone agonists
Adegoke et al. GnRH Antagonists in the Treatment of Uterine Fibroids
CA2341974A1 (fr) Antagoniste de l'hormone de liberation des gonadotrophines
Helvacioglu Gonadotropin Releasing Hormone Treatment
Gudmundsson et al. Peptide contraception by inhibition of ovulation with intranasal GnRH superagonist: clinical and metabolic aspects

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead